|
⚲
|
| Keyboard |
| Kahn Clare
✚
|
|
|---|---|
| CIK # | 0001849236 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001849236] | |
| 4 | [0001849236] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kahn Clare | |
| Solid Biosciences Inc | |
| Stoke Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Solid Biosciences Inc SLDB
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 77,500 | $0.00 | |
|
Solid Biosciences Inc SLDB
Common Stock
|
2025-03-11 | Buy | 1,860 | $5.34 | 9,932 |
|
Solid Biosciences Inc SLDB
Director Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 34,400 | $0.00 | |
|
Solid Biosciences Inc SLDB
Common Stock
|
2024-06-07 | Buy | 1,100 | $7.67 | 8,437 |
|
Solid Biosciences Inc SLDB
Director Stock Option (Right to Buy) · derivative
|
2023-06-06 | Grant | 9,650 | $0.00 | |
|
Solid Biosciences Inc SLDB
Director Stock Option (Right to Buy) · derivative
|
2022-12-13 | Grant | 9,650 | $0.00 | |
|
Solid Biosciences Inc SLDB
Director Stock Option (Right to Buy) · derivative
|
2022-06-07 | Grant | 51,000 | $0.00 | |
|
Solid Biosciences Inc SLDB
Stock Option (Right to Buy) · derivative
|
2022-06-07 | Grant | 40,000 | $0.00 | |
|
Solid Biosciences Inc SLDB
Stock Option (Right to Buy) · derivative
|
2021-03-02 | Grant | 40,000 | $0.00 |